Eric Daniel Tetzlaff
Fox Chase Cancer Center
22 Papers
65 Citations
Eric Daniel Tetzlaff is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Medicine & Burnout. The author has an hindex of 8, co-authored 13 publications.
Chat about Author
Papers
A Call to Action: Ethics Committee Roundtable Recommendations for Addressing Burnout and Moral Distress in Oncology.
Fay J. Hlubocky,Lynne P Taylor,Jonathan M. Marron,Rebecca Spence,Molly M. McGinnis,Richard F. Brown,Daniel C. McFarland,Eric Daniel Tetzlaff,Colleen M. Gallagher,Abby R. Rosenberg,Beth Popp,Konstantin H. Dragnev,Linda D. Bosserman,Denise M. Dudzinski,Sonali M. Smith,Monica Chatwal,Manali I. Patel,Merry Jennifer Markham,Kathryn Levit,Eduardo Bruera,Ronald M. Epstein,Marie T. Brown,Anthony L. Back,Tait D. Shanafelt,Arif H. Kamal +24 more
TL;DR: The causes of and interventions for burnout and moral distress in oncology are discussed, existing interventions are highlighted, and recommendations for addressing burnouts and improving well-being at the individual and organizational levels are provided to deliver ethical, quality cancer care.
64
Review of docetaxel in the treatment of gastric cancer.
TL;DR: This review focuses on the treatment of advanced gastric cancer utilizing docetaxel-based therapy and the novel additions of biotherapy to the existing cytotoxic platforms.
Creating a Blueprint of Well-Being in Oncology: An Approach for Addressing Burnout From ASCO's Clinician Well-Being Taskforce
Fay J. Hlubocky,Tait D. Shanafelt,Anthony L. Back,Judith A. Paice,Eric Daniel Tetzlaff,Christopher R. Friese,Arif H. Kamal,Daniel C. McFarland,Laurie J. Lyckholm,Colleen M. Gallagher,Monica Chatwal,Joel N. Saltzman,Denise M. Dudzinski,John M. Burke,Ted A. James,Ray D. Page,Deborah A. Boyle,Maria M Gonzalez,Piyush Srivastava +18 more
- 27 May 2021
TL;DR: The Clinician Well-being Task Force was created to improve the quality, safety, and value of cancer care by enhancing oncology clinician well-being and practice sustainability as discussed by the authors.
23
Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer.
Marion E. Cole,Shobha Parajuli,Douglas W. Laske,Lori J. Goldstein,Tara Morrison,Abir Mukherjee,Kathryn Tumelty,Eric Daniel Tetzlaff,Margaret von Mehren,Susan Inniss +9 more
TL;DR: This case highlights the importance of considering the impact of prior intensive therapies, including radiation and chemotherapy, on predisposing to future PNET/EWS and establishing the proper diagnosis of this “small blue cell tumor” is critical.
Dose escalating study of crenolanib besylate in advanced GIST patients with PDGFRA D842V activating mutations.
Margaret von Mehren,Eric Daniel Tetzlaff,Meghan Macaraeg,Jeremy Davis,Vartika Agarwal,Abhijit Ramachandran,Michael Heinrich +6 more
TL;DR: PDGFRA D842V mutated GIST is resistant to all available TKIs and crenolanib is a unique type I inhibitor of PDGFRα with in vitro act...
21